Skip to content

Insider · CIK 0001555508

Madhavan Balachandran

director

Files at QURE (uniQure N.V.), REPL (Replimune Group, Inc.). First filing Jun 24, 2025, latest Jun 24, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $31k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

QURE: uniQure N.V.

QUREOct 9, 2026 · close 22.59

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
35Weak
QUREsell 9
uniQure N.V.
$31k
2,112 shares
-5%+213% from low-21% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 20, 2025QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares
-2,112$14.45$31k37,697Jun 24, 2025
Jun 11, 2025QURE
uniQure N.V.
AGrant or award
Ordinary Shares
+7,970$0.00$039,809Jun 13, 2025
Jun 11, 2025QURE
uniQure N.V.
AGrant or award
Stock Option (Right to Buy)derivative
+15,630$0.00$015,630Jun 13, 2025
Apr 1, 2025REPL
Replimune Group, Inc.
AGrant or award
Stock Option (right to buy)derivative
+32,000$0.00$032,000Apr 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Madhavan Balachandran: insider trades and track record | InsiderTell